Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) appointed Wang Lei as chairman of the board, according to a Tuesday filing on the Singapore Exchange.
Wang has been with the company since 1993 and has held key roles including general manager and executive director. She holds a doctorate in engineering and is a senior engineer.
Wang succeeded Zhang Mingrui, who resigned from the post, effective Nov. 25, due to a change in work assignments, according to a separate filing on the same day.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。